1. Home
  2. ACXP vs TISI Comparison

ACXP vs TISI Comparison

Compare ACXP & TISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACXP
  • TISI
  • Stock Information
  • Founded
  • ACXP 2017
  • TISI 1973
  • Country
  • ACXP United States
  • TISI United States
  • Employees
  • ACXP N/A
  • TISI N/A
  • Industry
  • ACXP Biotechnology: Pharmaceutical Preparations
  • TISI Other Consumer Services
  • Sector
  • ACXP Health Care
  • TISI Consumer Discretionary
  • Exchange
  • ACXP Nasdaq
  • TISI Nasdaq
  • Market Cap
  • ACXP 8.4M
  • TISI 80.2M
  • IPO Year
  • ACXP 2021
  • TISI N/A
  • Fundamental
  • Price
  • ACXP $0.47
  • TISI $18.02
  • Analyst Decision
  • ACXP Strong Buy
  • TISI
  • Analyst Count
  • ACXP 2
  • TISI 0
  • Target Price
  • ACXP $10.00
  • TISI N/A
  • AVG Volume (30 Days)
  • ACXP 18.7M
  • TISI 14.7K
  • Earning Date
  • ACXP 08-08-2025
  • TISI 08-07-2025
  • Dividend Yield
  • ACXP N/A
  • TISI N/A
  • EPS Growth
  • ACXP N/A
  • TISI N/A
  • EPS
  • ACXP N/A
  • TISI N/A
  • Revenue
  • ACXP N/A
  • TISI $851,327,000.00
  • Revenue This Year
  • ACXP N/A
  • TISI N/A
  • Revenue Next Year
  • ACXP N/A
  • TISI N/A
  • P/E Ratio
  • ACXP N/A
  • TISI N/A
  • Revenue Growth
  • ACXP N/A
  • TISI N/A
  • 52 Week Low
  • ACXP $0.30
  • TISI $8.15
  • 52 Week High
  • ACXP $3.33
  • TISI $26.77
  • Technical
  • Relative Strength Index (RSI)
  • ACXP 52.38
  • TISI 39.69
  • Support Level
  • ACXP $0.45
  • TISI $18.20
  • Resistance Level
  • ACXP $0.59
  • TISI $19.28
  • Average True Range (ATR)
  • ACXP 0.08
  • TISI 1.06
  • MACD
  • ACXP -0.01
  • TISI -0.02
  • Stochastic Oscillator
  • ACXP 27.06
  • TISI 13.80

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

Share on Social Networks: